Natural essential oils derived from herbal medicines: A promising therapy strategy for treating cognitive impairment

Cognitive impairment (CI), mainly Alzheimer’s disease (AD), continues to increase in prevalence and is emerging as one of the major health problems in society. However, until now, there are no first-line therapeutic agents for the allopathic treatment or reversal of the disease course. Therefore, the development of therapeutic modalities or drugs that are effective, easy to use, and suitable for long-term administration is important for the treatment of CI such as AD. Essential oils (EOs) extracted from natural herbs have a wide range of pharmacological components, low toxicity, and wide sources, In this review, we list the history of using volatile oils against cognitive disorders in several countries, summarize EOs and monomeric components with cognitive improvement effects, and find that they mainly act by attenuating the neurotoxicity of amyloid beta, anti-oxidative stress, modulating the central cholinergic system, and improving microglia-mediated neuroinflammation. And combined with aromatherapy, the unique advantages and potential of natural EOs in the treatment of AD and other disorders were discussed. This review hopes to provide scientific basis and new ideas for the development and application of natural medicine EOs in the treatment of CI.

[1]  Yuan Zhang,et al.  Bromo-protopine, a novel protopine derivative, alleviates tau pathology by activating chaperone-mediated autophagy for Alzheimer’s disease therapy , 2022, Frontiers in Molecular Biosciences.

[2]  A. Bera,et al.  Reduction of kinesin I heavy chain decreases tau hyperphosphorylation, aggregation, and memory impairment in Alzheimer’s disease and tauopathy models , 2022, Frontiers in Molecular Biosciences.

[3]  K. Cheung,et al.  Tetrandrine ameliorates cognitive deficits and mitigates tau aggregation in cell and animal models of tauopathies , 2022, Journal of Biomedical Science.

[4]  Shi-Jie Zhang,et al.  Ligustilide Improves Cognitive Impairment via Regulating the SIRT1/IRE1α/XBP1s/CHOP Pathway in Vascular Dementia Rats , 2022, Oxidative medicine and cellular longevity.

[5]  Yinhui Li,et al.  Real-Time Detection and Visualization of Amyloid-β Aggregates Induced by Hydrogen Peroxide in Cell and Mouse Models of Alzheimer’s Disease , 2022, ACS applied materials & interfaces.

[6]  Shi-Jie Zhang,et al.  Ligustilide ameliorates cognitive impairment via AMPK/SIRT1 pathway in vascular dementia rat , 2022, Metabolic Brain Disease.

[7]  Yin Tang,et al.  Effects of Peppermint Essential Oil on Learning and Memory Ability in APP/PS1 Transgenic Mice , 2022, Molecules.

[8]  Lin F. Yang,et al.  Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019 , 2022, The Lancet. Public health.

[9]  K. Shyamprasad,et al.  A standardized black pepper seed extract containing β-caryophyllene improves cognitive function in scopolamine-induced amnesia model mice via regulation of brain-derived neurotrophic factor and MAPK proteins. , 2021, Journal of food biochemistry.

[10]  G. Cui,et al.  Oxyphylla A ameliorates cognitive deficits and alleviates neuropathology via the Akt-GSK3β and Nrf2-Keap1-HO-1 pathways in vitro and in vivo murine models of Alzheimer's disease , 2021, Journal of advanced research.

[11]  K. Rajaram,et al.  Alzheimer's Disease and other Tauopathies: Exploring Efficacy of Medicinal Plant-Derived Compounds in Alleviating Tau-Mediated Neurodegeneration. , 2021, Current molecular pharmacology.

[12]  Shen-Shih Chiang,et al.  Ameliorating Effect on Aβ-Induced Alzheimer’s Mice by Litsea cubeba Persoon Powder , 2021, Molecules.

[13]  Zhongshen Kuang,et al.  β-Asarone Attenuates Aβ-Induced Neuronal Damage in PC12 Cells Overexpressing APPswe by Restoring Autophagic Flux , 2021, Frontiers in Pharmacology.

[14]  A. Secondo,et al.  The Antioxidant Activity of Limonene Counteracts Neurotoxicity Triggered byAβ1-42 Oligomers in Primary Cortical Neurons , 2021, Antioxidants.

[15]  S. Tufik,et al.  Lavender essential oil on postmenopausal women with insomnia: double-blind randomized trial. , 2021, Complementary therapies in medicine.

[16]  K. Cho,et al.  Linalool Alleviates Aβ42-Induced Neurodegeneration via Suppressing ROS Production and Inflammation in Fly and Rat Models of Alzheimer's Disease , 2021, Oxidative medicine and cellular longevity.

[17]  Hyung-Won Kang,et al.  A systematic literature review and meta-analysis of the clinical effects of aroma inhalation therapy on sleep problems , 2021, Medicine.

[18]  Jing Cheng,et al.  Ginkgolide B promotes oligodendrocyte precursor cell differentiation and survival via Akt/CREB/bcl-2 signaling pathway after white matter lesion , 2021, Experimental biology and medicine.

[19]  H. Isoda,et al.  Dietary administration of cumin-derived cuminaldehyde induce neuroprotective and learning and memory enhancement effects to aging mice , 2021, Aging.

[20]  Hong-Bing Wang,et al.  Essential Oil of Acorus tatarinowii Schott Ameliorates Aβ-Induced Toxicity in Caenorhabditis elegans through an Autophagy Pathway , 2020, Oxidative medicine and cellular longevity.

[21]  P. Yaghmaei,et al.  Effects of Terpinolene and Physical Activity on Memory and Learning in a Model of Alzheimer's Disease among Rats , 2020, Qom Univ Med Sci J.

[22]  J. Jia,et al.  Prevalence, risk factors, and management of dementia and mild cognitive impairment in adults aged 60 years or older in China: a cross-sectional study. , 2020, The Lancet. Public health.

[23]  L. Hritcu,et al.  Thymus vulgaris Essential Oil Protects Zebrafish against Cognitive Dysfunction by Regulating Cholinergic and Antioxidants Systems , 2020, Antioxidants.

[24]  X. Yao,et al.  Nrf2: a dark horse in Alzheimer's disease treatment , 2020, Ageing Research Reviews.

[25]  A. Badr,et al.  Sesame oil mitigates memory impairment, oxidative stress, and neurodegeneration in a rat model of Alzheimer's disease. A pivotal role of NF-κB/p38MAPK/BDNF/PPAR-γ pathways. , 2020, Journal of ethnopharmacology.

[26]  Kalpesh Panara,et al.  Central nervous system depressant activity of Jatamansi (Nardostachys jatamansi DC.) rhizome , 2020, Ayu.

[27]  Shu Yang,et al.  The effectiveness of aromatherapy on preoperative anxiety in adults: A systematic review and meta-analysis of randomized controlled trials. , 2020, International journal of nursing studies.

[28]  Antonio Massa,et al.  Lavender and coriander essential oils and their main component linalool exert a protective effect against amyloid‐β neurotoxicity , 2020, Phytotherapy research : PTR.

[29]  A. Boguszewska-Czubara,et al.  Bergapten Improves Scopolamine-Induced Memory Impairment in Mice via Cholinergic and Antioxidative Mechanisms , 2020, Frontiers in Neuroscience.

[30]  Eric E. Smith,et al.  Recommendations of the 5th Canadian Consensus Conference on the diagnosis and treatment of dementia , 2020, Alzheimer's & dementia : the journal of the Alzheimer's Association.

[31]  S. Singh,et al.  Role of antioxidants and a nutrient rich diet in Alzheimer's disease , 2020, Open Biology.

[32]  Xu Gao,et al.  Lemon essential oil ameliorates age-associated cognitive dysfunction via modulating hippocampal synaptic density and inhibiting acetylcholinesterase , 2020, Aging.

[33]  Changwei Wei,et al.  Vascular cognitive impairment and dementia in type 2 diabetes mellitus: An overview. , 2020, Life sciences.

[34]  Yuan Cheng,et al.  Peripheral clearance of brain-derived Aβ in Alzheimer's disease: pathophysiology and therapeutic perspectives , 2020, Translational Neurodegeneration.

[35]  P. Mortazavi,et al.  Effect of β-asarone in normal and β-amyloid-induced Alzheimeric rats , 2020, Archives of medical science : AMS.

[36]  G. Eren,et al.  Cognitive Facilitation and Antioxidant Effects of an Essential Oil Mix on Scopolamine-Induced Amnesia in Rats: Molecular Modeling of In Vitro and In Vivo Approaches , 2020, Molecules.

[37]  Liping Huang,et al.  β-asarone modulates Beclin-1, LC3 and p62 expression to attenuate Aβ40 and Aβ42 levels in APP/PS1 transgenic mice with Alzheimer's disease , 2020, Molecular medicine reports.

[38]  Qi Wang,et al.  Ligustilide improves aging-induced memory deficit by regulating mitochondrial related inflammation in SAMP8 mice , 2020, Aging.

[39]  R. Gabizon,et al.  Brain targeting of 9c,11t-Conjugated Linoleic Acid, a natural calpain inhibitor, preserves memory and reduces Aβ and P25 accumulation in 5XFAD mice , 2019, Scientific Reports.

[40]  Shi-feng Chu,et al.  Effect of α-asarone on ethanol-induced learning and memory impairment in mice and its underlying mechanism. , 2019, Life sciences.

[41]  Mengjie Xu,et al.  Essential oil of Schisandra chinensis ameliorates cognitive decline in mice by alleviating inflammation. , 2019, Food & function.

[42]  M. Nair,et al.  Alzheimer’s disease: pathogenesis, diagnostics, and therapeutics , 2019, International journal of nanomedicine.

[43]  L. Robison,et al.  Sex differences in risk factors for vascular contributions to cognitive impairment & dementia , 2019, Neurochemistry International.

[44]  L. D. de Souza,et al.  Alzheimer’s disease: risk factors and potentially protective measures , 2019, Journal of Biomedical Science.

[45]  O. Cioancă,et al.  Pinus halepensis essential oil attenuates the toxic Alzheimer's amyloid beta (1-42)-induced memory impairment and oxidative stress in the rat hippocampus. , 2019, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[46]  O. Cioancă,et al.  Tetraclinis articulata essential oil mitigates cognitive deficits and brain oxidative stress in an Alzheimer's disease amyloidosis model. , 2019, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[47]  S. Agatonovic-Kustrin,et al.  Essential oils and functional herbs for healthy aging , 2019, Neural regeneration research.

[48]  P. Tariot,et al.  Present Algorithms and Future Treatments for Alzheimer’s Disease , 2019, Journal of Alzheimer's disease : JAD.

[49]  R. Ihl,et al.  Treatment of dementia and mild cognitive impairment with or without cerebrovascular disease: Expert consensus on the use of Ginkgo biloba extract, EGb 761® , 2019, CNS neuroscience & therapeutics.

[50]  Anil Kumar,et al.  Targeting oxidative stress, acetylcholinesterase, proinflammatory cytokine, dopamine and GABA by eucalyptus oil (Eucalyptus globulus) to alleviate ketamine-induced psychosis in rats , 2019, Inflammopharmacology.

[51]  Yong-Ku Kim,et al.  Effectiveness of memantine on depression-like behavior, memory deficits and brain mRNA levels of BDNF and TrkB in rats subjected to repeated unpredictable stress , 2018, Pharmacological reports : PR.

[52]  M. Mesulam,et al.  The cholinergic system in the pathophysiology and treatment of Alzheimer's disease. , 2018, Brain : a journal of neurology.

[53]  Wei Wang,et al.  α-Cyperone inhibits LPS-induced inflammation in BV-2 cells through activation of Akt/Nrf2/HO-1 and suppression of the NF-κB pathway. , 2018, Food & function.

[54]  K. Koike,et al.  The effect of inhalation of essential oil from Rosmarinus officinalis on scopolamine‐induced Alzheimer's type dementia model mice , 2018 .

[55]  H. Kuang,et al.  Cognitive enhancement of volatile oil from the stems of Schisandra chinensis Baill. in Alzheimer's disease rats. , 2018, Canadian journal of physiology and pharmacology.

[56]  O. Badary,et al.  Protective effects of thymoquinone on D-galactose and aluminum chloride induced neurotoxicity in rats: biochemical, histological and behavioral changes , 2018, Neurological research.

[57]  W. Hsu,et al.  Mechanism of intranasal drug delivery directly to the brain , 2018, Life sciences.

[58]  Gyu Hwan Park,et al.  Neuroprotective Effect and Molecular Mechanism of [6]-Gingerol against Scopolamine-Induced Amnesia in C57BL/6 Mice , 2018, Evidence-based complementary and alternative medicine : eCAM.

[59]  R. Mizrahi,et al.  Molecular imaging of neuroinflammation in Alzheimer's disease and mild cognitive impairment , 2018, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[60]  M. Kim,et al.  Natural Dietary Supplementation of Anthocyanins via PI3K/Akt/Nrf2/HO-1 Pathways Mitigate Oxidative Stress, Neurodegeneration, and Memory Impairment in a Mouse Model of Alzheimer’s Disease , 2018, Molecular Neurobiology.

[61]  Guy M. McKhann,et al.  Associations Between Midlife Vascular Risk Factors and 25-Year Incident Dementia in the Atherosclerosis Risk in Communities (ARIC) Cohort , 2017, JAMA neurology.

[62]  Meizhu Wang,et al.  Rose Essential Oil Delayed Alzheimer's Disease-Like Symptoms by SKN-1 Pathway in C. elegans. , 2017, Journal of agricultural and food chemistry.

[63]  M. Power,et al.  Defining the Relationship Between Hypertension, Cognitive Decline, and Dementia: a Review , 2017, Current Hypertension Reports.

[64]  Alan J. Thomas,et al.  Clinical practice with anti-dementia drugs: A revised (third) consensus statement from the British Association for Psychopharmacology , 2011, Journal of psychopharmacology.

[65]  J. Gutiérrez Rodríguez,et al.  [Definition and prevalence of mild cognitive impairment]. , 2017, Revista espanola de geriatria y gerontologia.

[66]  Ming Yan,et al.  Protective effect of lavender oil on scopolamine induced cognitive deficits in mice and H2O2 induced cytotoxicity in PC12 cells. , 2016, Journal of ethnopharmacology.

[67]  Liping Huang,et al.  β-asarone improves learning and memory and reduces Acetyl Cholinesterase and Beta-amyloid 42 levels in APP/PS1 transgenic mice by regulating Beclin-1-dependent autophagy , 2016, Brain Research.

[68]  G. Cardona-Gómez,et al.  Linalool reverses neuropathological and behavioral impairments in old triple transgenic Alzheimer's mice , 2016, Neuropharmacology.

[69]  P. VandeVord,et al.  Role of Glia in Memory Deficits Following Traumatic Brain Injury: Biomarkers of Glia Dysfunction , 2016, Front. Integr. Neurosci..

[70]  J. Francis-Oliveira,et al.  Reactive Oxygen Species: Physiological and Physiopathological Effects on Synaptic Plasticity , 2016, Journal of experimental neuroscience.

[71]  Elyse Rosa,et al.  CREB expression mediates amyloid β-induced basal BDNF downregulation , 2015, Neurobiology of Aging.

[72]  Han-Chang Huang,et al.  Protection of curcumin against amyloid-β-induced cell damage and death involves the prevention from NMDA receptor-mediated intracellular Ca2+ elevation , 2015, Journal of receptor and signal transduction research.

[73]  R. Nitsch,et al.  Calcium flux-independent NMDA receptor activity is required for Aβ oligomer-induced synaptic loss , 2015, Cell Death and Disease.

[74]  N. Iwata,et al.  Memantine Monotherapy for Alzheimer’s Disease: A Systematic Review and Meta-Analysis , 2015, PloS one.

[75]  O. Garaschuk,et al.  Neuroinflammation in Alzheimer's disease , 2015, The Lancet Neurology.

[76]  L. Tan,et al.  Brain-Derived Neurotrophic Factor in Alzheimer’s Disease: Risk, Mechanisms, and Therapy , 2015, Molecular Neurobiology.

[77]  S. Lipton,et al.  Oligomeric Aβ-induced synaptic dysfunction in Alzheimer’s disease , 2014, Molecular Neurodegeneration.

[78]  Liping Huang,et al.  Beta-asarone attenuates amyloid beta-induced autophagy via Akt/mTOR pathway in PC12 cells. , 2014, European journal of pharmacology.

[79]  Brian C Coe,et al.  Alzheimer's Disease-Like Pathology Induced by Amyloid-β Oligomers in Nonhuman Primates , 2014, The Journal of Neuroscience.

[80]  Mary Ganguli,et al.  Dementia and cognitive impairment: epidemiology, diagnosis, and treatment. , 2014, Clinics in geriatric medicine.

[81]  K. Shinya,et al.  Amyloid aggregation and deposition of human islet amyloid polypeptide at membrane interfaces , 2014, The FEBS journal.

[82]  M. Mihăşan,et al.  Inhalation of coriander volatile oil increased anxiolytic–antidepressant-like behaviors and decreased oxidative status in beta-amyloid (1–42) rat model of Alzheimer's disease , 2014, Physiology & Behavior.

[83]  A. Spector,et al.  Aromatherapy for dementia. , 2014, The Cochrane database of systematic reviews.

[84]  Zhang Chunxi Effects of Active Components of Rhizoma Acori Tatarinowii on APP and Synaptic Ultrastructure in Tg-APPswe/ PS1dE9 Mice , 2014 .

[85]  Jin-Tai Yu,et al.  Efficacy and safety of donepezil, galantamine, rivastigmine, and memantine for the treatment of Alzheimer's disease: a systematic review and meta-analysis. , 2014, Journal of Alzheimer's disease : JAD.

[86]  C. Bouras,et al.  Neuropathology of parkinsonism in patients with pure Alzheimer's disease. , 2014, Journal of Alzheimer's disease : JAD.

[87]  S. Rai,et al.  Mechanism of Oxidative Stress and Synapse Dysfunction in the Pathogenesis of Alzheimer’s Disease: Understanding the Therapeutics Strategies , 2014, Molecular Neurobiology.

[88]  F. Islam,et al.  1,8-Cineole (Eucalyptol) Mitigates Inflammation in Amyloid Beta Toxicated PC12 Cells: Relevance to Alzheimer’s Disease , 2014, Neurochemical Research.

[89]  M. Mesulam,et al.  Cholinergic circuitry of the human nucleus basalis and its fate in Alzheimer's disease , 2013, The Journal of comparative neurology.

[90]  M. Mihăşan,et al.  Cognitive-enhancing and antioxidant activities of inhaled coriander volatile oil in amyloid β(1–42) rat model of Alzheimer's disease , 2013, Physiology & Behavior.

[91]  D. Bredesen,et al.  Ayurvedic medicinal plants for Alzheimer's disease: a review , 2012, Alzheimer's Research & Therapy.

[92]  A. Gorji,et al.  Anticonvulsant and neuroprotective effects of Pimpinella anisum in rat brain , 2012, BMC Complementary and Alternative Medicine.

[93]  Jeongmin Lee,et al.  Inhaled essential oil from Chamaecyparis obtuse ameliorates the impairments of cognitive function induced by injection of β-amyloid in rats , 2012, Pharmaceutical biology.

[94]  Z. Azizi,et al.  Amelioration of Amyloid β‐Induced Cognitive Deficits by Zataria multiflora Boiss. Essential Oil in a Rat Model of Alzheimer's Disease , 2012, CNS neuroscience & therapeutics.

[95]  Hans-Ulrich Demuth,et al.  Prion-Like Behavior and Tau-dependent Cytotoxicity of Pyroglutamylated β-Amyloid , 2012, Nature.

[96]  W. Jian Molecular Mechanisms Underlie Alzheimer-like Tau Hyperphosphorylation and Neurodegeneration , 2012 .

[97]  B. Lyoussi,et al.  Antioxidant and Antiacetylcholinesterase Activities of Some Commercial Essential Oils and Their Major Compounds , 2011, Molecules.

[98]  S. Pugazhenthi,et al.  Downregulation of CREB expression in Alzheimer's brain and in Aβ-treated rat hippocampal neurons , 2011, Molecular Neurodegeneration.

[99]  Kuo-Chen Chou,et al.  A Multi-Label Classifier for Predicting the Subcellular Localization of Gram-Negative Bacterial Proteins with Both Single and Multiple Sites , 2011, PloS one.

[100]  Songhee Jeon,et al.  SuHeXiang Wan essential oil alleviates amyloid beta induced memory impairment through inhibition of tau protein phosphorylation in mice. , 2011, The American journal of Chinese medicine.

[101]  A. Lleó,et al.  β-Amyloid Disrupts Activity-Dependent Gene Transcription Required for Memory through the CREB Coactivator CRTC1 , 2010, The Journal of Neuroscience.

[102]  S. Yan,et al.  Role of mitochondrial amyloid-beta in Alzheimer's disease. , 2010, Journal of Alzheimer's disease : JAD.

[103]  Joseph E LeDoux,et al.  Brain-derived neurotrophic factor: a dynamic gatekeeper of neural plasticity. , 2010, Current molecular pharmacology.

[104]  K. Urakami,et al.  Effect of aromatherapy on patients with Alzheimer's disease , 2009, Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society.

[105]  Sang-H Choi,et al.  The distinct roles of cyclooxygenase-1 and -2 in neuroinflammation: implications for translational research. , 2009, Trends in pharmacological sciences.

[106]  Richard L Doty,et al.  The olfactory system and its disorders. , 2009, Seminars in neurology.

[107]  R. Hansen,et al.  Efficacy and safety of donepezil, galantamine, and rivastigmine for the treatment of Alzheimer’s disease: A systematic review and meta-analysis , 2008, Clinical interventions in aging.

[108]  I. Izquierdo,et al.  BDNF is essential to promote persistence of long-term memory storage , 2008, Proceedings of the National Academy of Sciences.

[109]  K. Mishima,et al.  Spatial memory impairment without apoptosis induced by the combination of beta-amyloid oligomers and cerebral ischemia is related to decreased acetylcholine release in rats. , 2008, Journal of pharmacological sciences.

[110]  A. Sartorius,et al.  Elevated spectroscopic glutamate/&ggr;-amino butyric acid in rats bred for learned helplessness , 2007, Neuroreport.

[111]  P. Tariot,et al.  Meta-analysis of six-month memantine trials in Alzheimer’s disease , 2007, Alzheimer's & Dementia.

[112]  D. Jun Effect of rhizoma acori graminei on the secondary structure of amyloid beta-protein 25-35 , 2007 .

[113]  T. Joh,et al.  Microglia, major player in the brain inflammation: their roles in the pathogenesis of Parkinson's disease , 2006, Experimental & Molecular Medicine.

[114]  V. Perry,et al.  Central and Systemic Endotoxin Challenges Exacerbate the Local Inflammatory Response and Increase Neuronal Death during Chronic Neurodegeneration , 2005, The Journal of Neuroscience.

[115]  E. Ongini,et al.  Non‐steroidal anti‐inflammatory drugs (NSAIDs) in Alzheimer's disease: old and new mechanisms of action , 2004, Journal of neurochemistry.

[116]  E. Green,et al.  A polymorphic variation in the interleukin 1A gene increases brain microglial cell activity in Alzheimer’s disease , 2004, Journal of Neurology, Neurosurgery & Psychiatry.

[117]  R. Maccioni,et al.  Interleukin-6 induces Alzheimer-type phosphorylation of tau protein by deregulating the cdk5/p35 pathway. , 2004, Experimental cell research.

[118]  H. W. Harris,et al.  Interleukin 1 regulates synthesis of amyloid beta-protein precursor mRNA in human endothelial cells. , 1989, Proceedings of the National Academy of Sciences of the United States of America.